These xenografts have proved a better engraftment of human AML and yielded more heterogeneity in leukemia stem cell populations including CD34+ CD38+ cell populations, suggesting the critical importance of the microenvironment in vivo [22,23]. This evidence concerns the gene CD38 and leukemia.